Santuril®
(500 mg probenecid containing tablets)
Probenecid, (4-(dipropylsulfamoyl) benzoic acid inhibits the organic anion-transport across cell membranes by binding to to the relevant membrane transporter polypeptides thereby increasing urinary uric acid excretion while decreasing renal excretion and increasing plasma levels of drugs (ATC-Code: M04AB01).
Santuril® (500 mg Probenecid containing tablets) is an uricosuric agent.